Keyphrases
Absolute Value
14%
ACE Genotype
14%
ACE Inhibition
14%
ACE Inhibitor Therapy
100%
ACE Inhibitors
28%
Active Treatment
28%
Angiotensin
28%
Angiotensin II (Ang II)
14%
Angiotensin-converting Enzyme
28%
Blood Pressure
28%
Clinical Practice
14%
Clinical Trials
14%
Coefficient of Variation
14%
Compliance Assessment
100%
Compliance with Treatment
28%
Congestive Heart Failure
14%
Drug Use
14%
Heart Failure Management
14%
Heart Rate
14%
Hemodynamic Effects
14%
Inhibitor Treatment
14%
Lisinopril
14%
Loop Diuretics
14%
Low Serum
14%
Male Volunteers
14%
Neurohormonal
28%
P-days
14%
Partial Compliance
42%
Patients with Heart Failure
14%
Placebo
42%
Poor Compliance
14%
Practical Assessment
100%
Randomized Double-blind
14%
Serum ACE Level
100%
Single-dose Treatment
14%
Suppression Effect
14%
Nursing and Health Professions
Angiotensin
16%
Angiotensin Derivative
16%
Artificial Intelligence
50%
Blood Pressure
33%
Clinical Practice
16%
Compliance
100%
Compliance with Treatment
33%
Congestive Heart Failure
33%
Dipeptidyl Carboxypeptidase
33%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Lisinopril
16%
Loop Diuretic Agent
16%
Placebo
50%
Single Drug Dose
33%
Volunteer
16%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin
33%
Angiotensin Derivative
33%
Clinical Trial
33%
Congestive Heart Failure
66%
Dipeptidyl Carboxypeptidase
66%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Lisinopril
33%
Loop Diuretic Agent
33%
Placebo
100%
Biochemistry, Genetics and Molecular Biology
Angiotensin
33%
Angiotensin-Converting Enzyme
66%
Artificial Intelligence
100%
Blood Pressure
66%
Clinical Trial
33%
Genotyping
33%
Hemodynamic
33%
Single Drug Dose
66%
Neuroscience
ACE Inhibitor
100%
Angiotensin
33%
Angiotensin Derivative
33%
Dipeptidyl Carboxypeptidase
66%
Lisinopril
33%
Loop Diuretic
33%
Placebo
100%